Participation of Necroptosis in the Host Response to Acute Bacterial Pneumonia

Danielle Ahn1, Alice Prince

  • 1Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.

Insights

Common lung bacteria trigger necroptosis, a cell death pathway, impacting pneumonia. This process can harm the host by depleting immune cells but may also aid pathogen clearance.

Area of Science:

  • Immunology
  • Cellular Biology
  • Pathogen-Host Interactions

Background:

  • Pneumonia pathogenesis involves common and healthcare-associated pathogens.
  • Necroptosis, a programmed cell death pathway (RIPK1/RIPK3/MLKL), is activated by various bacterial species.
  • Bacterial pore-forming toxins are a common mechanism for necroptosis induction.

Purpose of the Study:

  • To review the role of necroptosis in pneumonia pathogenesis.
  • To explore how necroptosis influences immune cell function and host response.
  • To discuss the implications of necroptosis in bacterial pneumonia.

Main Methods:

  • Review of existing literature on necroptosis and pneumonia.
  • Analysis of pathogen-induced cell death pathways.
  • Examination of immune cell responses to necroptosis.

Main Results:

  • Necroptosis activation by pathogens like Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, and Serratia marcescens.
  • Necroptosis can lead to immune cell loss (e.g., macrophages), contributing to host pathology.
  • In some cases, necroptosis promotes pathogen removal and controls inflammation.
  • Carbapenem-resistant Klebsiella pneumoniae ST258 activates necroptosis but suppresses CYLD expression.

Conclusions:

  • Necroptosis plays a dual role in pneumonia, potentially causing host damage or aiding pathogen clearance.
  • Understanding necroptosis regulation is crucial for developing future pneumonia therapies.
  • Further research is needed to elucidate the coregulation of necroptosis and other cell death mechanisms in response to pulmonary pathogens.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
7.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.7K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.4K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K